SK Hedge

trader/26

[SK Hedge @swishseb]

Times like these are when the real $$$ is made. Long $AMZN $ABNB

[SK Hedge @swishseb]

$HIMS 24.40 to 28.80 in 2 market days 🎯 volatility is why we love $HIMS if volatility scares you, don’t trade this stock.

[SK Hedge @swishseb]

$HIMS people comparing this lawsuit and expecting “$15” all of a sudden like the company hasn’t transformed since that time is hilarious. $25 is a gift and you’d have to back up the brinks truck if it went much lower. Not only did peptides get approved, but $HIMS is $NVO biggest telehealth partner. $NVO looked like they would ruin $HIMS at $15 but it got resolved in weeks. Now an ongoing 2023 investigation would do similar things? An investigation that simply leads to a fine? FUD at its finest. Panic if you want, you will buy the shares I sell shortly.

[SK Hedge @swishseb]

$HIMS +10%, i hope you didn’t panic 🤓 never doubt the $HIMS whisperer

[SK Hedge @swishseb]

$HIMS don’t panic, this lawsuit is nothing compared to what we dealt with in Feb. Much much easier to resolve. Be calm.

[SK Hedge @swishseb]

$HIMS +7%, imagine selling at 24-25 yesterday thinking the stock was going to hit yearly lows on a rehashed 2023 headline. I know my followers and I didn’t 🎯💰 We slam the buy when reaching institutional support levels. Be careful who you follow on X about $HIMS !

[SK Hedge @swishseb]

$HIMS people comparing this lawsuit and expecting “$15” all of a sudden like the company hasn’t transformed since that time is hilarious. $25 is a gift and you’d have to back up the brinks truck if it went much lower. Not only did peptides get approved, but $HIMS is $NVO biggest telehealth partner. $NVO looked like they would ruin $HIMS at $15 but it got resolved in weeks. Now an ongoing 2023 investigation would do similar things? An investigation that simply leads to a fine? FUD at its finest. Panic if you want, you will buy the shares I sell shortly.

[SK Hedge @swishseb]

$HIMS +5%, strong bounce off the institutional support level at $25. Expecting a ping pong at these prices between $25 and $27 until news/earnings. Great short term entry and line in the sand for strong trades 🎯

[SK Hedge @swishseb]

$HIMS back to institutional buy level. Massive opportunity here.

[SK Hedge @swishseb]

@stockmom Says the sub selling grifter with an AI picture 🤣

[SK Hedge @swishseb]

@michaelabina You shouldn’t be trading stocks then. Sheep mentality

[SK Hedge @swishseb]

$HIMS don’t panic, this lawsuit is nothing compared to what we dealt with in Feb. Much much easier to resolve. Be calm.

[SK Hedge @swishseb]

$HIMS the silver lining in all of this besides that we get christmas gift prices is - that perma gay bear paul cerro publicly disclosed a long in the mid 30s just before the crash. Poetic justice 🤣

[SK Hedge @swishseb]

$HIMS people comparing this lawsuit and expecting “$15” all of a sudden like the company hasn’t transformed since that time is hilarious. $25 is a gift and you’d have to back up the brinks truck if it went much lower. Not only did peptides get approved, but $HIMS is $NVO biggest telehealth partner. $NVO looked like they would ruin $HIMS at $15 but it got resolved in weeks. Now an ongoing 2023 investigation would do similar things? An investigation that simply leads to a fine? FUD at its finest. Panic if you want, you will buy the shares I sell shortly.

[SK Hedge @swishseb]

@moninvestor $15 happened on the back of a serious competitor and pharma giant $NVO coming after them AND the DOJ. This is nothing compared to that $HIMS.

[SK Hedge @swishseb]

$HIMS dealt with a much worse situation in Feb against $NVO and the DOJ. They resolved that in a matter of weeks and this is nothing compared to that. Slap on the wrist. I trust $HIMS

[SK Hedge @swishseb]

$HIMS back to institutional buy level. Massive opportunity here.

[SK Hedge @swishseb]

$HIMS director David Wells poured 1 million of his own money into the stock at $25. We are 3 points away. I’d consider that huge institutional support - and David Wells was recently on @himshouse podcast detailing why. Wouldn’t be surprised to see a buyback announcement here.

[SK Hedge @swishseb]

$HIMS ultimate bull signal

[Hardik Shah @AIStockSavvy]

Jim Cramer on $HIMS Hims & Hers Health : “Controversial stock. I really prefer to just own $LLY Eli Lilly.”

[SK Hedge @swishseb]

$HIMS +7% and reclaiming the $30 resistance level. Constructive.

[SK Hedge @swishseb]

$HIMS everybody wants to buy cheap until its time to buy cheap 💰

[SK Hedge @swishseb]

$HIMS director David Wells poured 1 million of his own money into the stock at $25. We are 3 points away. I’d consider that huge institutional support - and David Wells was recently on @himshouse podcast detailing why. Wouldn’t be surprised to see a buyback announcement here.

[SK Hedge @swishseb]

$HIMS my followers always have the blueprint 🎯

[SK Hedge @swishseb]

$HIMS peptides are not the make or break for this stock. Even if they are approved, it still takes 12-24 months for the FDA to legally act on them. This is all short term noise regardless, but I am feasting on shares if we get a panic dip these next few days. Be ready.

[SK Hedge @swishseb]

$HIMS everybody wants to buy cheap until its time to buy cheap 💰

[SK Hedge @swishseb]

$HIMS theres the panic dip! Made a great move by selling my scalp near the high and then let it collapse. Started buying back at 30 and ended with 28.90 avg. A lot of people crying “scam” don’t understand this is just the behavior of the stock. Overall high beta sell off + sell the news event like I highlighted in the quoted tweet. Don’t cry, just buy. Know what you own. $HIMS is trending #1 right now so a lot of uninformed and ignorant people spreading FUD. Don’t panic.

[SK Hedge @swishseb]

$HIMS peptides are not the make or break for this stock. Even if they are approved, it still takes 12-24 months for the FDA to legally act on them. This is all short term noise regardless, but I am feasting on shares if we get a panic dip these next few days. Be ready.

[SK Hedge @swishseb]

@AndrewDudum @dranantmd Need that Oura ring collab Andrew 😊 $HIMS

[SK Hedge @swishseb]

$HIMS those following into a short based on the Shrekli tweet will be severely punished. Although the chart is a little questionable, Martin was on $HIMS pod a year ago and supported the stock at a price similar to the one now. It’s clear his beef is with his opinions on peptides - not $HIMS. I wouldn’t be surprised if he actually didn’t short any at all. $HIMS is not a peptide stock! It’s just one of many verticals. They already make billions without it, and their $NVO partnership is ripe. $NVO already said $HIMS is their #1 partner and delivering exceptional volume. That mixed with hinted collabs of an oura ring collab by Dudum - plenty to be excited about besides peptides. Take advantage of the volatility and understand what the company is before blindly shorting off a tweet. Relative strength is also massive compared to the blood bath of a market.